Meропенем Аптафарма (Meropenem Trihydrate)

Meropenem, the active ingredient in Meропенем Аптафарма, is a carbapenem antibiotic presented as an unknown strength/unknown form for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, hospital‑acquired pneumonia and septic shock in adult patients.

GNH USA supplies Meропенем Аптафарма as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem used for serious bacterial infections affecting various organ systems.

- Complicated intra‑abdominal infections: provides bactericidal activity against mixed aerobic and anaerobic pathogens to achieve clinical cure. - Complicated urinary tract infections: eradicates resistant Gram‑negative organisms to resolve infection. - Hospital‑acquired pneumonia: targets multidrug‑resistant bacteria to improve respiratory outcomes. - Ventilator‑associated pneumonia: offers coverage of likely pathogens in intubated patients. - Severe sepsis and septic shock: delivers rapid bacterial killing to support hemodynamic stabilization.

Adverse reactions may occur with meropenem therapy and are categorized by frequency.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Headache: transient and often resolves without intervention. - Rash: erythematous skin eruption. - Elevated liver enzymes: transient increase in transaminases. - Phlebitis at infusion site: local irritation.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disease. - Clostridioides difficile infection: severe colitis risk. - Anaphylaxis: acute hypersensitivity reaction. - Severe neutropenia: marked reduction in white blood cells. - Renal toxicity: acute kidney injury in susceptible individuals. - Hypersensitivity reactions: including Stevens‑Johnson syndrome.

Meropenem requires careful clinical monitoring to minimize risks.

- Renal impairment: adjust dose based on creatinine clearance. - Hypersensitivity: avoid in patients with known carbapenem allergy. - Pregnancy: use only if benefit outweighs potential risk; data are limited. - Seizure risk: monitor neurologic status, especially in CNS‑compromised patients. - Superinfection: watch for overgrowth of non‑susceptible organisms. - Store at ambient temperature: keep in original container, protect from light and moisture.

Meropenem may interact with other medicines, necessitating vigilance.

Major Interactions (Avoid): - Valproic acid: carbapenems reduce serum valproate levels, risking seizure breakthrough. - Concurrent carbapenems: additive nephrotoxicity. - High‑dose aminoglycosides: increased risk of renal toxicity. - Warfarin: may potentiate anticoagulant effect, requiring INR monitoring. - Live vaccines: immunosuppression may diminish vaccine efficacy.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance electrolyte disturbances. - NSAIDs: potential additive renal effects. - Oral contraceptives: possible reduction in contraceptive efficacy. - Phenytoin: may alter plasma concentrations. - Other antibiotics: risk of antagonism or additive toxicity.